Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)
China flag China · Delayed Price · Currency is CNY
28.33
+0.52 (1.87%)
At close: Mar 6, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Pharmaceutical Wholesale and Retail
144.04M204.09M220.96M183.84M136.70M
Pharmaceutical Wholesale and Retail Growth
-29.43%-7.63%20.19%34.49%16.69%
Pharmaceutical Manufacturing
202.97M310.46M308.45M447.34M485.09M
Pharmaceutical Manufacturing Growth
-34.62%0.65%-31.05%-7.78%-7.36%
Unallocated Other Business Income/Costs
4.19M5.07M3.03M1.77M979.98K
Unallocated Other Business Income/Costs Growth
-17.26%67.09%71.27%80.63%-5.27%
Total
351.20M519.62M532.44M632.95M622.77M
Total Growth
-32.41%-2.41%-15.88%1.64%-2.97%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
China
351.20M519.62M532.44M632.95M622.77M
China Growth
-32.41%-2.41%-15.88%1.64%-2.97%
Total
351.20M519.62M532.44M632.95M622.77M
Total Growth
-32.41%-2.41%-15.88%1.64%-2.97%
Source: S&P Global Market Intelligence.